3759 — Pharmaron Beijing Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$38.39bn
- HK$44.40bn
- CNY14.10bn
Annual cashflow statement for Pharmaron Beijing Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | CAS | CAS | CAS | CAS | CAS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -3,849 | -5,634 | -6,357 | -7,181 | -8,008 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 2,058 | 2,143 | 2,754 | 2,577 | 3,221 |
| Capital Expenditures | -2,093 | -2,950 | -2,865 | -2,041 | -2,669 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -3,165 | 741 | 614 | 16.4 | -1,705 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -5,258 | -2,209 | -2,251 | -2,024 | -4,374 |
| Financing Cash Flow Items | -653 | -990 | 731 | -494 | -204 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 3,661 | -1,417 | 3,915 | -4,797 | 377 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 416 | -1,410 | 4,429 | -4,166 | -780 |